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Abstract
Background: We recently showed that whereas inhibition of PI3K/akt or JAK/STAT pathway
promoted retinal ganglion cell (RGC) survival after optic nerve (ON) injury in Fischer 344 (F344)
rats, the same inhibition resulted in aggravated RGC loss after acute intraocular pressure (IOP)
elevation in Sprague Dawley (SPD) rats. In addition, the responses of macrophages to ON injury
and acute IOP elevation were different between F344 and Lewis rats, i.e., different autoimmune
profiles. Using an acute IOP elevation paradigm in this study, we investigated 1) whether
autoimmune background influences PI3K/akt and JAK/STAT functions by examining the effect of
PI3K/akt and JAK/STAT pathway inhibition on RGC survival in F344 and Lewis rats, and 2) whether
differential actions of macrophages occur in PI3K/akt and JAK/STAT pathways-dependent
modulation of RGC survival. IOP elevation was performed at 110 mmHg for 2 hours. PI3K/akt and
JAK/STAT pathway inhibitors were applied intravitreally to block their respective pathway signaling
transduction. Because macrophage invasion was seen in the eye after the pathway inhibition, to
examine the role of these pathways independent of macrophages, macrophages in the retina were
removed by intravitreal application of clodronate liposomes. Viable RGCs were retrogradely
labelled by FluoroGold 40 hours before animal sacrifice.
Results: Similar to what was previously observed, significantly more RGCs were lost in Lewis than
F344 rats 3 weeks after acute IOP elevation. As in SPD rats, inhibition of the PI3K/akt or JAK/STAT
pathway increased the loss of RGCs in both F344 and Lewis rats. Removal of macrophages in the
eye by clodronate liposomes reduced RGC loss due to pathway inhibition in both strains.
Conclusion: This study demonstrates that following acute IOP elevation 1) PI3K/akt and JAK/
STAT pathways mediate RGC survival in both F344 and Lewis rats, 2) autoimmune responses do
not influence the functions of these two pathways, and 3) PI3K/akt and JAK/STAT pathway
inhibition-dependent activation of macrophages is detrimental to RGCs.
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Background
Loss of retinal ganglion cells (RGCs) occurs in many path-
ological situations, and glaucoma is one of the common
diseases that lead to RGC loss. A common feature of glau-
coma is elevation of intraocular pressure (IOP) that causes
progressive axonal degeneration and loss of RGCs. As
acute glaucoma is characterised by rapid increase in IOP,
acute IOP elevation paradigm in rodents has often been
used to study acute IOP elevation-induced retinal
ischemic/reperfusion injury and the possible mechanisms
underlying acute glaucoma-associated RGC injuries [1-5].
It is known that immune responses can influence neuro-
nal survival after injury. Whereas ample evidence pointed
to a damaging effect of inflammatory responses of macro-
phages and T-cells after CNS injury and in autoimmune
diseases such as multiple sclerosis and experimental
autoimmune encephalomyelitis (EAE) [6-13], T-cell
dependent RGC protection in response to IOP elevation
has also been reported in EAE-resistant Fischer 344 (F344)
but not EAE-vulnerable Lewis rats [14]. In our earlier
study, we found that macrophages, which are another
major component of the autoimmune system, responded
differently to IOP elevation or optic nerve (ON) injury
between F344 and Lewis rats, and such differences led to
different extents of RGC survival after IOP elevation or
ON injury [15,16]. Macrophage activation in the eye by
intravitreal injection of zymosan, a yeast wall preparation,
protected RGCs after ON injury whereas the same activa-
tion aggravated RGC loss following acute IOP elevation
[15-17]. In addition, under the same condition of either
ON injury or acute IOP elevation the same macrophage
activation resulted in different extents of RGC survival or
loss between F344 and Lewis rats [16,17].
Phosphatidylinositol 3-kinase (PI3K)/akt and janus
kinase (JAK/STAT3) signal pathways are well known to
mediate neuronal survival [18-25]. Recently we showed
that ON injury or acute IOP elevation activates both path-
ways in the ganglion cell layer (GCL) [26-28]. However,
our recent work also points to paradoxic actions of these
two pathways in RGC survival under different pathologi-
cal conditions. Though both ON injury and acute IOP ele-
vation activate PI3K/akt and JAK/STAT pathways in the
GCL, including RGCs, inhibition of these signalling path-
ways activates macrophages in the eye and contributes to
RGC survival after ON injury in F344 rats [28]. However,
the same pathway inhibition leads to RGC loss following
acute IOP elevation in Sprague Dawley (SPD) rats [26,27].
In addition, as mentioned above, we also showed that
macrophage activation in the eye by intravitreal injection
of zymosan played a protective role in RGCs after ON
injury [15,28]. But the same macrophage activation
resulted in aggravated RGC loss in an IOP elevation
model of the same F344 rat strain [17]. Macrophages thus
appear to play an important role in the differences in RGC
viability under the two pathological conditions.
F344 and Lewis rats are inbred strains. They differ in sus-
ceptibility to EAE. It is known that the hypothalamic-pitu-
itary-adrenal (HPA) axis modulates autoimmune
response and vulnerability to EAE. In contrast to F344
rats, Lewis rats have abnormalities in HPA function. Vari-
ation in genotypes that are associated with different dis-
ease phenotypes between F344 and Lewis rats have been
reported [29]. Furthermore, the greater frequency of CD8+
regulatory T cells, which functionally inhibit myelin basic
protein-reactive T-cells, in F344 than in Lewis rats might
contribute to the differing susceptibility to EAE between
them [30]. It is currently unknown whether, after acute
IOP elevation, 1) inhibition of the PI3K/akt or JAK/STAT
pathway aggravates RGC loss in F344 and Lewis rats, 2)
autoimmune background influences PI3K/akt and JAK/
STAT signaling pathways in RGC survival, and 3) differen-
tial actions of macrophages occur in PI3K/akt and JAK/
STAT pathway-dependent modulation of RGC survival.
PI3K/akt and JAK/STAT pathways play an important role
in mediating RGC survival following acute IOP elevation
in SPD rats [26,27]. Autoimmune background is also
known to modulate neuronal viability [16,17]. It is there-
fore important to clarify the issues as mentioned above.
This study, using F344 and Lewis rats, was designed to
accomplish these tasks.
Results
Effect of inhibition of PI3/akt and JAK/STAT pathways on 
RGC viability in F344 rats
Representative photomicrographs showing the appear-
ances of FG-labelled viable RGCs (left column) and ED1+
macrophages (right column) in normal F344 and Lewis
rats or 3 weeks after acute IOP elevation plus various
experimental interventions are shown in Figure 1. The
appearances of FG-labelled viable RGCs 3 weeks after
acute IOP elevation alone in both F344 and Lewis rats
were previously shown [17]. Compared with normal
intact F344 (A) and Lewis (G) rats, significant loss of
RGCs was seen 3 weeks after acute IOP elevation and
pathway inhibition of PI3K/akt in both strains (C and I,
respectively). Clodronate liposomes significantly reduced
the number of macrophages in the eye of both strains and,
compared with the same strain of rats not receiving
clodornate liposomes, significantly enhanced the number
of surviving RGCs. However, the extent of surviving RGCs
after macrophage removal was still below the intact con-
trol, especially in Lewis rats. Similar observations were
seen after PI3K/akt pathway inhibition by LY294002 or
JAK/STAT pathway inhibition by AG490 and Jak Inhibitor
I (images not shown). More surviving RGCs were seen in
the central than the peripheral region. No clear change inBMC Neuroscience 2008, 9:78 http://www.biomedcentral.com/1471-2202/9/78
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the retinal thickness was observed before and after the
acute IOP elevation [27].
The average numbers ± SEM of surviving RGCs and ED1+
macrophages were 2356 ± 125/retina and 11 ± 2/retina,
respectively, in intact F344 rats (n = 4). The average num-
bers ( ± SEM) of surviving RGCs in the retinas of the IOP
elevation only group (n = 6) and the inhibitor carrier
DMSO group (n = 5) were not significantly different from
each other (1514 ± 78/retina versus 1314 ± 103/retina;
Fig. 2A). Intravitreal application of DMSO marginally
increased the number of macrophages (81 ± 10/retina ver-
sus 137 ± 9/retina) in the eye (Fig. 2A). LY303511, the
negative control of LY294002 and which contains a single
atom substitution in the morpholine ring compared to
LY294002 and does not inhibit PI3K even at high concen-
trations, did not affect RGC survival, but substantially
increased the number of macrophages in the eye (n = 5;
Fig. 2A). Compared with the negative control LY303511
and DMSO groups, significant decreases in RGC survival
were observed after intravitreal application of PI3K/akt
pathway inhibitor LY294002 or KY12420 (n = 5 in each
Representative fluorescent photomicrographs of retinal  wholemounts showing characteristics of retrogradely FG- labeled surviving RGCs (left column) and ED1+ macrophages  (right column) Figure 1
Representative fluorescent photomicrographs of ret-
inal wholemounts showing characteristics of retro-
gradely FG-labeled surviving RGCs (left column) and 
ED1+ macrophages (right column). A and B, normal 
F344 rat; C and D, after application of pathway inhibitor 
KY12420 in IOP-elevated F344 rat; E and F, after application 
of pathway inhibitor KY12420 and clodonate liposomes in 
IOP-elevated F344 rat; G and H, normal Lewis rat; I and J, 
after application of pathway inhibitor KY12420 in IOP-ele-
vated Lewis rat; K and L, after application of pathway inhibi-
tor KY12420 and clodonate liposomes in IOP-elevated Lewis 
rat. More surviving RGCs were seen in F344 than Lewis rats 
after IOP elevation and pathway inhibition (C versus I). After 
removal of macrophages by clodronate liposomes, the num-
bers of surviving RGCs increased in both F344 (E versus C) 
and Lewis (K versus I) rats. Similar results were obtained 
after inhibition of JAK/STAT pathway (images not shown). 
Scale bar = 50 μm.
Average densities (± SEM) of FG-labeled surviving RGCs and  ED1+ macrophages after inhibition of PI3K/akt and JAK/STAT  pathways in F344 rats Figure 2
Average densities (± SEM) of FG-labeled surviving 
RGCs and ED1+ macrophages after inhibition of 
PI3K/akt and JAK/STAT pathways in F344 rats. Signifi-
cant decrease in RGC viability and concomitant increase in 
the number of macrophages were seen following PI3k/akt 
and JAK/STAT pathway inhibition (A). After macrophage 
removal (B), pathway inhibition-induced RGC loss was signif-
icantly but not completely prevented, indicating that both 
macrophage and PI3k/akt and JAK/STAT pathways were 
involved in RGC viability in this strain of rat. *p < 0.05, **p < 
0.01 and ***p < 0.001 against DMSO group unless specified.BMC Neuroscience 2008, 9:78 http://www.biomedcentral.com/1471-2202/9/78
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group; Fig. 2A). Concomitant with the decrease in RGC
survival was a significant increase in the number of mac-
rophages in the retina (Fig. 2A). Significant decrease in the
number of surviving RGCs was also seen after intravitreal
application of JAK/STAT pathway inhibitor AG490 or Jak
Inhibitor I (n = 5 and 6, respectively; Fig. 2A). Accompa-
nying the decrease in RGC survival was a significant
increase in the number of macrophages in the retina (Fig.
2A). These observations are thus similar to what was seen
after inhibition of PI3K/akt and JAK/STAT pathways in
SPD rats [26,27]. Our earlier studies using Western blot-
ting showed that the pathway inhibitors used at these con-
centrations effectively, though not completely, blocked
collective signal transduction of the pathways [26-28].
Effects of macrophage removal on RGC viability in F344 
rats
We applied a macrophage remover, clodronate lipo-
somes, intravitreally to deplete macrophages in the eye
[26-28,31]. As expected, clodronate liposomes applied
alone or in combination with KY12420 (n = 5 each group)
significantly reduced the number of macrophages in the
eye to a level slightly higher than that in DMSO group
(Fig. 2B). Concomitant with this reduction of macro-
phages in the eye was significant improvement but not
complete recovery in RGC survival in KY12420-treated
F344 rats (Fig. 2B). Similarly, an increased number of sur-
viving RGCs was also seen after co-application of clodro-
nate liposomes with JAK/STAT pathway inhibitor AG490
(n = 5; Fig. 2B). The improvement but not complete recov-
ery of RGC survival after macrophage removal in PI3K/akt
or Jak/STAT pathway-inhibited eyes suggested that macro-
phages and the pathways modulated, in opposite direc-
tions, RGC survival after acute IOP elevation in F344 rats.
Effect of inhibition of PI3K/akt and JAK/STAT pathways on 
RGC viability in Lewis rats
The average numbers ± SEM of surviving RGCs and ED1+
macrophages were 2583 ± 82/retina and 8 ± 1/retina,
respectively, in intact Lewis rats (n = 4). The average num-
bers ( ± SEM) of surviving RGCs and ED1+macrophages in
the retinas of IOP elevation only (n = 5) and DMSO (n =
4) groups were not significantly different from each other
in Lewis rats (Fig. 3A). However, the number of surviving
RGCs 3 weeks after acute IOP elevation was significantly
(6-fold) lower in Lewis than F344 rats (Fig. 2A and 3A).
LY303511 also did not affect RGC survival although it
marginally increased the number of macrophages in Lewis
rats (n = 5; Fig. 3). Even though the levels of RGC survival
were already low in the negative control and DMSO
groups (Fig. 3A), further decrease in RGC survival was still
seen after intravitreal application of PI3K/akt pathway
inhibitor LY294002 or KY12420 (n = 5 each group). Con-
comitant with the decrease in RGC survival was a signifi-
cant increase in the number of macrophages in the retina
(Fig. 3A). Similarly, intravitreal applications of JAK/STAT
pathway inhibitor AG490 or Jak Inhibitor I (n = 5 each
group) also resulted in a significant decrease in the
number of surviving RGCs and a significant increase in
the number of macrophages in the retina (Fig. 3).
Effects of macrophage removal on RGC viability in Lewis 
rats
Similar to what occurred in F344 rats, clodronate lipo-
somes applied alone (n = 5) or co-applied with KY12420
(n = 4) or AG490 (n = 5) significantly reduced the number
of macrophages in the retina to a level lower than that in
the DMSO group (Fig. 3B). Concomitant with the reduc-
tions of macrophages in the eye was significant improve-
ment but not complete recovery in RGC survival in
KY12420- and AG490-treated Lewis rats (Fig. 3B). These
findings suggested that PI3K/akt and JAK/STAT pathways
and macrophages are involved in RGC viability in similar
fashion to that in F344 rats following acute IOP elevation.
Average densities (± SEM) of FG-labeled surviving RGCs and  ED1+ macrophages after inhibition of PI3K/akt and JAK/STAT  pathways in Lewis rats Figure 3
Average densities (± SEM) of FG-labeled surviving 
RGCs and ED1+ macrophages after inhibition of 
PI3K/akt and JAK/STAT pathways in Lewis rats. Signif-
icant decrease in RGC viability and concomitant increase in 
the number of macrophages were seen following PI3k/akt 
and JAK/STAT pathway inhibition (A). After macrophage 
removal (B), pathway inhibition-induced RGC loss was signif-
icantly but not completely prevented, indicating that both 
macrophage and the pathways were also involved in RGC 
viability in Lewis rats. Note that the numbers of surviving 
RGCs were significantly lower in Lewis than F344 rats. *p < 
0.05, **p < 0.01 and ***p < 0.001 against DMSO group unless 
specified.BMC Neuroscience 2008, 9:78 http://www.biomedcentral.com/1471-2202/9/78
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To clarify whether the observed reduction of RGC counts
after inhibitor application resulted from interfered trans-
port of FG, we carried out another experiment in which
both FG and immunohistochemical approaches were
used to label RGCs of the same retinas and the numbers
of RGCs between the 2 approaches were compared. Com-
pared with the number of TUJ1-immunostained RGCs of
the same retinas, there were an average of 15% (n = 3)
decrease and 12% (n = 3) increase in the numbers of FG-
labeled RGCs in KY12420 and AG490 treatment groups,
repsectively. The small differences between the 2 labelling
approaches are not statistically significant, indicating that
the intravitreal application of the pathway inhibitors does
not influence the efficacy of the FG transport. Note that
FG was applied 20 hours whereas the data presented
below were obtained from rats that received FG 5 days
after the administration of the pathway inhibitors. The
further delayed application of FG rendered the inhibitors
less likely to affect the retrograde transport of FG.
Discussion
In this study we investigated the roles of PI3K/akt and
JAK/STAT pathways and macrophages in RGC viability
after acute IOP elevation in F344 and Lewis rats, which are
known to have different autoimmune profiles. We show
that in both rat strains, inhibition of PI3K/akt or JAK/
STAT pathway reduces RGC survival and activates macro-
phages in the eye. In addition, both macrophage activa-
tion and PI3K/akt and JAK/STAT pathways mediate RGC
viability, in opposite directions, after acute IOP elevation.
PI3K/akt and JAK/STAT are known to be the major signal-
ling executors for neuronal survival [19,20,24,25,32-36].
Whereas PI3K/akt is the common signal transduction
pathway underlying neurotrophin-induced biological
actions, JAK/STAT is well-documented to be responsible
for cytokine-induced effects [37]. Previously we showed
that the pathway inhibitors applied at dosages as in this
study significantly inhibited signal transduction of the
respective pathways [26-28,38]. The clear differences in
RGC survival or in macrophage recruitment between eyes
treated with LY294002 and with its negative control
LY303511 following IOP elevation in both F344 and
Lewis rats are similar to what was seen in SPD rats [26,27].
These results confirmed that the actions of LY294002 on
RGC viability and macrophage recruitment are dependent
on PI3k/akt pathway-inhibition. The persistent loss of
RGCs after PI3K/akt or JAK/STAT pathway inhibition in
the absence of ocular macrophages (following clodronate
liposome application) in both strains further verify that
these signal transduction pathways mediate RGC survival
following acute IOP elevation independent of influence of
autoimmune background.
Previously T-cells were shown to play a part in differential
protection of RGCs following episcleral and limbal vein
cauterization-induced IOP elevation in F344 and Lewis
rats [14]. In our earlier study, we showed that macrophage
reactions to acute IOP elevation were also different in rats
with different autoimmune backgrounds [17]. In the
present study we demonstrated that in contrast to the
actions on macrophages, autoimmune background did
not modulate signal transduction pathways of PI3K/akt
and JAK/STAT in RGC survival.
Conclusion
PI3K/akt and JAK/STAT pathway mediate RGC survival
after acute IOP elevation and autoimmune background
does not influence the functional roles of these pathways.
In addition, PI3K/akt and JAK/STAT pathway inhibition-
induced macrophage activation in the eye is detrimental
to RGCs following acute IOP elevation.
Methods
A total number of 108 young adult (8–10 weeks old) F344
and Lewis rats were used, and each experimental group
consisted of 4–6 rats. All experiments conformed to The
Chinese University of Hong Kong Animal Experimenta-
tion Ethic Committee (AEEC) guidelines and were
approved by the AEEC. All possible measures were taken
to minimize suffering and limit the number of rats used in
this study. All surgery was carried out under anaesthesia
with a 1:1 mixture (1.5 ml/kg) of ketamine (100 mg/ml)
and xylazine (20 mg/ml).
Acute IOP elevation and the experimental groups
The acute IOP elevation procedure has previously been
reported [39]. Briefly, a 27-gauge needle was placed in the
anterior chamber of the left eye. The needle was con-
nected to a container carrying 500 ml sterile normal
saline. The container was raised to a height of 1496 mm
above the eye to elevate the IOP to 110 mmHg for 2 hrs.
Each strain of rats was allocated to different experimental
groups after acute IOP elevation. The first group received
no intravitreal injections and served as intact controls. The
second group received intravitreal injections of DMSO (3
μl each injection), which is the inhibitor carrier. The third
group received intravitreal injections of LY303511 (Calbi-
ochem, San Diego, USA; 2 mM × 3 μl), which was the neg-
ative control of PI3k/akt pathway inhibitor LY294002.
The fourth and fifth groups received intravitreal injections
of PI3k/akt pathway inhibitors LY294002 [2-(4-Mor-
pholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochlo-
ride, Sigma; 2 mM × 3 μl and KY12420 (Calbiochem, San
Diego, USA; 2 mM × 3 μl), respectively. The sixth and sev-
enth groups received intravitreal injections of JAK/STAT
pathway inhibitors AG490 [α-Cyano-(3,4-dihydroxy)-N-
benzylcinnamide, Calbiochem; USA; 2 mM × 3 μl] and
Jak Inhibitor I [2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihy-
dro-7H-benz[h]-imidaz [4,5-f]isoquinolin-7-one; Calbio-
chem; 2 mM × 3 μl], respectively. Two inhibitors of each
pathway, coupled with the available negative control,BMC Neuroscience 2008, 9:78 http://www.biomedcentral.com/1471-2202/9/78
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LY303511, were used in aim to clarify or exclude the pos-
sibility of chemical effects of these inhibitors on RGC via-
bility.
As macrophage activation has been seen to accompany
acute IOP elevation and inhibition of PI3k/akt and JAK/
STAT pathways, we used clodronate liposomes to remove
macrophages in the eye and examined what roles macro-
phages and the two pathways played in RGC viability. In
this part, 1 group received intravitreal injection (3 μl, once
only) of clodronate liposomes immediately after acute
IOP elevation, 2 groups received immediate intravitreal
injection (3 μl, once only) of clodronate liposomes that
were followed by 3 intravitreal injections of KY12420 and
AG490, respectively, 3, 9 and 15 days later. Both clodro-
nate and liposomes (if prepared of phosphatidylcholine
and cholesterol) are not toxic. Liposome-encapsulated
clodronate and liposomes containing PBS only (control
liposomes) were prepared as previously described [40].
Clodronate was a gift of Roche Diagnostics GmbH (Man-
nheim, Germany). Phosphatidylcholine was obtained
from Lipoid GmbH (Ludwigshafen, Germany), and cho-
lesterol purchased from Sigma. Recently we showed that
both PBS liposomes and clodronate liposomes applied at
this dosage into the eye were not detrimental to RGCs
[28,31]. All rats survived for 3 weeks after acute IOP eleva-
tion.
For intravitreal injections of DMSO or the inhibitors, each
rat received three posterior chamber eye injections on
days 3, 9 and 15 after IOP elevation. Intravitreal injection
of 3 μl clodronate liposomes was carried out once only on
the day of IOP elevation, which was 3 days prior to path-
way inhibitor injection. For the eye injection, the micropi-
pette was deliberately angled to avoid damage to the lens
[41].
Retrograde labeling of viable RGCs
To retrogradely label viable RGCs, a small piece of gel-
foam soaked with 4% FluoroGold (FG, Fluorochrome Inc,
Denver, USA) was applied at the newly cut stump of the
proximal ON to retrogradely label viable RGCs. Animals
survived for another 40 hours to maximize retrograde
transport of the dye. Note that RGCs only start to die 5
days after ON axotomy in adult rats [42]. While deeply
anaesthetized, the rats were perfused with cold 4% para-
formaldehyde in phosphate buffer (0.1 M, pH 7.4). After
dissection from the eye-cups, the retinas were post-fixed
in 4% paraformaldehyde for 45 min, flat-mounted and
temporarily coverslipped in anti-fading medium (Dako
Corporation, Carpinteria, CA, USA). The number of FG-
labelled RGCs in each field (0.25 × 0.25 mm2), sampled
at a fixed distance from one another and in a pattern of
grid intersections, was counted throughout the whole ret-
ina. A total of 70–80 fields, about 8–10% of the total ret-
inal area, were sampled per retina. The average density of
viable RGCs was obtained. This approach avoided prob-
lems associated with uneven distribution of RGCs in the
retina.
In a separate experiment, we examined whether intravit-
real application of the pathway inhibitors influenced the
retrograde transport of FG. One inhibitor of each pathway
(AG490 for JAK/STAT pathway and KY12420 for PI3K/akt
pathway) was injected intravitreally into eyes of normal
rats (n = 3 each group). FG was applied in the same way
as above 20 hours after the inhibitor application, and the
rats were killed 40 hours after FG application. After count-
ing the number of FG-labeled RGCs, the retinas were
immunostained for RGCs using the TUJ1 monoclonal
antibody (against βIII-tubulin, BabCO, Richmond, CA,
USA). βIII-tubulin has been shown to be an RGC-specific
marker in retinal wholemounts [15,16,28,31,38,43,44].
Immunohistochemical staining of macrophages
After counting the number of FG-labeled RGCs, retinas
were used for immunostaining of macrophages. The reti-
nas were thoroughly washed with PBS and blocked with
10% normal goat serum (NGS), 1% bovine serum albu-
min (BSA) and 0.2% Triton for 1 hour. They were then
immunostained overnight at 4°C with ED1 antibody
(1:200, Serotec, Oxford, UK) [15,28], were rinsed with
PBS and incubated with conjugated Cy3 (Jackson Immu-
noResearch Laboratories, West Grove, PA, USA; 1:400)
secondary antibody overnight at 4°C. After 3 washes each
for 5 minutes, the retinas were mounted with anti-fading
fluorescence mounting medium and examined under the
fluorescent microscope. ED1 positive (+) cells were
counted in the same way as for FG-labeled RGCs.
Statistical analysis
Data on RGCs from the different groups were pooled and
statistically analysed using Bonferroni test following one-
way analysis of variance (ANOVA). Bonferroni test was
used to compare mean values among all intra-groups
[15,38].
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